Shenzhen MGI Technology Co., Ltd

Short Form Report on Changes in Equity

Listed company: Shenzhen MGI Technology Co., Ltd

Listed on the Shanghai Stock Exchange

Stock abbreviation: MGI

Stock Code: 688114. SH

One of the information disclosure obligors: CPE Investment (Hong Kong) 2018 Limited

Registration/correspondence address: Room 3201, 32nd Floor, One Pacific Place, 88 Queensway, Admiralty, Hong Kong

Information Disclosure Obligor 2: CHD Biotech Co-invest Limited

Registered address: Kingston Chambers, PO Box 173, Road Town, Tortola, British Virgin Islands

Correspondence address: Room 3201, 32/F, One Pacific Place, 88 Queensway, Admiralty, Hong Kong

Nature of change in shares: reduction and passive dilution

Date of signing: April 15, 2025

Disclosure Obligor Statement

1. This report is prepared by the information disclosure obligor in accordance with the Company Law of the People's Republic of China, the Securities Law of the People's Republic of China, the Administrative Measures for the Acquisition of Listed Companies, and the Guidelines for the Content and Format of Information Disclosure of Companies Offering Securities to the Public No. 15 - Report on Changes in Equity and other relevant laws, regulations and normative documents.

2. The information disclosure obligor has obtained the necessary authorization and approval to sign this report.

3. In accordance with the Securities Law of the People's Republic of China, the Administrative Measures for the Acquisition of Listed Companies, and the Standards for the Content and Format of Information Disclosure of Companies Offering Securities to the Public No. 15 - Report on Changes in Equity, this report has fully disclosed the changes in the shares of the equity interests of Shenzhen MGI Technology Co., Ltd. owned by the information disclosure obligor.

As of the date of this report, except for the shareholding information disclosed in this report, the information disclosure obligor has not increased or decreased its shares in Shenzhen MGI Technology Co., Ltd. by any other means.

4. The change in equity is based on the information contained in this report. Except for the person obligated to disclose this information, no other person has been entrusted or authorized to provide information not contained in this report and to give any explanation or explanation to this report.

5. The information disclosure obligor undertakes that there are no false records, misleading statements or material omissions in this report, and assumes individual and joint legal liability for its authenticity, accuracy and completeness.

Table of Contents

Disclosure Obligor Statement ...... 2

Section 1: Interpretation ...... 4

Section 2: Introduction to Information Disclosure Obligors ...... 5

Section 3 Purpose of Changes in Equity ...... 7

Section 4 Methods of Change of Equity ...... 8

Section 5 Trading of MGI Shares in the First Six Months ...... 10

Section 6 Other Major Matters ...... 11

Section 7 Documents for Reference ...... 12

Schedule:...... 17

Section 1: Interpretation

In this report, unless otherwise specified, the following shall have the following meanings:

Listed companies, companies, this refers to Shenzhen MGI Technology Co., Ltd

Company, MGI

Information Disclosure Obligor means CPE Investment (Hong Kong) 2018 Limited, CHD Biotech Co-invest

Limited

This report and report refer to the short-form report on changes in equity of Shenzhen MGI Technology Co., Ltd

On April 15, 2025, the information disclosure obligor will reduce its holdings of the company in aggregate through inquiry and transfer

6,210,256 RMB ordinary shares, representing 1.49% of the total share capital of the listed company. furthermore

This change in equity refers to the changes in equity due to the Company on October 21, 2022, May 10, 2023, and October 16, 2024

In 2020, the completion of the exercise of the stock option incentive plan led to an increase in the company's total share capital, and the obligation to disclose information

The shareholding ratio of the individual is passively diluted by 0.05% of the total share capital.

Yuan means the Chinese Yuan Yuan

Any discrepancies between the total and the sum of the details in this report are due to rounding.

Section 2: Introduction of Information Disclosure Obligors

1. Basic information of the information disclosure obligor

(1) One of the persons obligated to disclose information

Company name CPE Investment (Hong Kong) 2018 Limited

Type of enterprise: Foreign-funded enterprise

Registered address: Room 3201, 32/F, One Pacific Place, 88 Queensway, Admiralty, Hong Kong

NIE Lei、CHAN Ching Nar Cindy、YONG Leong Chu, Yonn、KWONG

Directors Man Kin (Alternate Director to NIE Lei), TANG Pak Leung (Alternate

Director to CHAN Ching Nar Cindy）、TAN Inn Hwee （Alternate

Director to YONG Leong Chu, Yonn）

Date of establishment November 28, 2018

Company number 2770926

$1 of issued share capital

Main business: foreign investment and provision of consulting services

Communication: Room 3201, 32/F, One Pacific Place, 88 Queensway, Admiralty, Hong Kong

The shareholding structure of CPE Investment (Hong Kong) 2018 Limited is as follows:

Serial No. Name Contribution Ratio

1 Cayenne Private Enterprise III Limited 100%

Total 100%

Key Persons in Charge of CPE Investment (Hong Kong) 2018 Limited:

Other countries or places

Name, Position, Gender, Nationality, Long-term residence

District of abode

YONG

Leong Chu, Director Female Singapore Singapore None

Yonn

(2) The second person with the obligation to disclose information

Business name CHD Biotech Co-invest Limited

Type of enterprise: Foreign-funded enterprise

Registered address Kingston Chambers, PO Box 173, Road Town, Tortola, British Virgin

Islands

Directors LU Yifei, CHAN Ching Nar Cindy, YONG Leong Chu, Yonn, TANG

Pak Leung（Alternate Director to CHAN Ching Nar Cindy）

Date of establishment May 4, 2020

Company number 2035662

The issued share capital is US$600,631

Main business: foreign investment

Communication: Room 3201, 32/F, One Pacific Place, 88 Queensway, Admiralty, Hong Kong

The shareholding structure of CHD Biotech Co-invest Limited is as follows:

Serial No. Name Contribution Ratio

1 CPECHINA Fund III, L.P. 100%

Total 100%

CHD Biotech Co-invest Limited:

Other countries or places

Name, Position, Gender, Nationality, Long-term residence

District of abode

YONG

Leong Chu, Director Female Singapore Singapore None

Yonn

2. Explanation of the relationship between the persons obligated to disclose information acting in concert

CPE Investment (Hong Kong) 2018 Limited is the same as CHD Biotech Co-invest Limited

Action people.

3. The shares in which the information disclosure obligor has an interest in other listed companies at home or abroad reach or exceed 5% of the issued shares of the company

As of the date of this report, the information disclosure obligor does not have an interest in other listed companies in China or overseas that reaches or exceeds 5% of the issued shares of the company.

Section 3: Purpose of Changes in Equity and Interests

1. The purpose of the change in the rights and interests of the information disclosure obligor

The change in equity is caused by the reduction of the shareholding ratio of the information disclosure obligor due to its own capital needs and the passive dilution of the shareholding ratio.

2. The information disclosure obligor's share increase or decrease plan in the next 12 months

1. As of the date of signing this report, the information disclosure obligor has no plans to increase its holdings in the next 12 months.

2. As of the date of signing this report, the information disclosure obligor has no disclosed shareholding reduction plan in the next 12 months.

Section 4: Methods of Changes in Equity and Interests

1. The basic situation of the change in rights and interests

The method of this equity change is: the information disclosure obligor reduces the shares of the listed company by way of inquiry transfer,

In addition, due to the completion of the exercise of the company's 2020 stock option incentive plan, the company's total share capital increased, and the information was disclosed

The obligor's shareholding ratio is passively diluted.

This change in equity will not result in a change in the control of MGI.

2. Shareholdings before and after the change in equity

Before and after this change in equity, the information disclosure obligor holds the shares of the listed company as follows:

Shares held before this change Shares held after this change

Name of shareholder Nature of shares Number of shares Number of shares

(shares) as a percentage of total share capital (shares) as a percentage of total share capital

CPE total holdings 26,378,788 6.39% 20,306,788 4.88%

Investment Where: Unlimited - - 20,306,788 4.88%

(Hong Conditional Shares.)

Kong) is available in limited quantities

2018 Conditional Shares 26,378,788 6.39% - -

Limited

CHD Total Holding 600,631 0.15% 462,375 0.11%

Biotech Which: Unlimited - - 462,375 0.11%

Co-invest Conditional Shares

Limited 600,631 0.15% - -

Conditional shares

Total 26,979,419 6.53% 20,769,163 4.99%

Note: The "number of shares (shares)" in the "shares held before this change" refers to the number of shares held by the information disclosure obligor at the time of the company's listing

Measure. The "proportion of shares held before this change" is based on the total share capital of the company after the completion of the listing and issuance of 413,110,000

Share-based measurement; The "proportion of shares held after this change" is signed by the company as of this report

The total daily share capital is 416,516,155 shares.

3. The main situation of this equity change

The information disclosure obligor reduced its holdings of the listed company by way of inquiry transfer, in addition, due to the company's 2020

The total share capital of the company increased due to the completion of the exercise of the stock option incentive plan, and the shareholding ratio of the information disclosure obligor was passively thin

The percentage of equity held in the company has been reduced to less than 5%.

On April 15, 2025, the information disclosure obligor reduced its holdings of the company by 6,210,256 through inquiry transfer

RMB ordinary shares, representing 1.49% of the total share capital of the Company. In addition, October 21, 2022, to

On May 10, 2023 and October 16, 2024, the exercise of the company's 2020 stock option incentive plan was completed

The total share capital of Bizhi Company increased, and the shareholding ratio of the information disclosure obligor passively diluted 0.05% of the total share capital.

The details of this equity change are as follows:

Name of shareholder Method of change Date of change Type of equity Number of shares reduced Change ratio

(shares) example

CPE RFQ Transfer 15 April 2025 RMB ordinary shares 6,072,000 1.46%

Investment Other October 21, 2022 RMB Ordinary Shares

(Hong 16 Oct 2024 - 0.05%

Kong) 2018 Total - - 6,072,000 1.51%

Limited

Inquiry Transfer 15 April 2025 RMB ordinary shares 138,256 0.03%

CHD

Biotech Other Oct 21, 2022 to RMB Ordinary - 0.00%

Co-invest October 16, 2024

Limited Total

- - 138,256 0.03%

Note 1: The change method "Other" refers to the total share capital of the Company due to the completion of the exercise of the Company's 2020 stock option incentive plan

increase, the proportion of shares held by the information disclosure obligor is passively diluted.

4. Restrictions on the rights and interests of the discloser

As of the date of signing of this report, there is no pledge, freezing or other restriction on the shares of MGI held by the information disclosure obligor.

Section 5 Trading of MGI shares within the previous six months

In the six months prior to the date of this report, the information disclosure obligor did not buy or sell the shares of MGI.

Section 6: Other major matters

As of the date of signing this report, the information disclosure obligor has truthfully disclosed the relevant information of the change in equity in accordance with the relevant regulations, and there is no other material information that should be disclosed by the information disclosure obligor in accordance with the applicable law and in order to avoid misunderstanding of the content of this report.

Section 7: Documents for reference

1. Catalogue of documents for reference

1. A copy of the registration certificate of the information disclosure obligor;

2. List of directors and their main responsible persons of the information disclosure obligor and their identification documents;

3. The report on the change of equity signed by the information disclosure obligor;

4. Other documents required by the China Securities Regulatory Commission or the stock exchange for reference.

2. Location of access

The full text of this report and the documents for reference are placed in Shenzhen MGI Technology Co., Ltd. for investors' inspection.

Disclosure Obligor Statement

I (and the organization I represent) undertake that there are no false records, misleading statements or material omissions in this report, and I assume individual and joint legal responsibility for its authenticity, accuracy and completeness.

Information Disclosure Obligor (Seal): CPE Investment (Hong Kong) 2018 Limited

(Signed):

April 15, 2025

Disclosure Obligor Statement

I (and the organization I represent) undertake that there are no false records, misleading statements or material omissions in this report, and I assume individual and joint legal responsibility for its authenticity, accuracy and completeness.

Information disclosure obligor (seal): CHD Biotech Co-invest Limited

(Signed):

April 15, 2025

(There is no text on this page, it is the "Report on Changes in Equity in Simplified Form of Shenzhen MGI Technology Co., Ltd.")

Signature page)

Information Disclosure Obligor (Seal): CPE Investment (Hong Kong) 2018 Limited

(Signed):

April 15, 2025

(There is no text on this page, it is the "Report on Changes in Equity in Simplified Form of Shenzhen MGI Technology Co., Ltd.")

Signature page)

Information disclosure obligor (seal): CHD Biotech Co-invest Limited

(Signed):

April 15, 2025

Schedule:

Short Form Report on Changes in Equity

Basic information

Shenzhen MGI is a listed company located in Yantian District, Shenzhen, Guangdong Province

Name of Listed Company Technology Co., Ltd. Beishan Industrial Zone Complex Building and 1

2nd floor, 1st building, company

Stock abbreviation: MGI Stock code: 688114.SH

CPE Investment, 88 Queensway, Admiralty, Hong Kong

(Hong Kong) 32/F, 32/F, One Pacific Place

Information Disclosure Obligation 2018 Limited, Information Disclosure Obligation Room 01, Kingston Cham

Name CHD Biotech Person is registered at bers, PO Box 173, Ro

Co-invest Limit ad Town, Tortola, Brit

ed ish Virgin

Islands

Shares with interest Increase □ Decrease ■ Whether there is concerted action

The change in quantity remains the same, but the number of shareholders has no □

People change □

Information Disclosure Obligor Information Disclosure Obligation

Whether it is a listed company Yes□ No■ Whether the person is listed Yes□ No■

The largest shareholder is actually controlled by the company

person

Centralized trading through the stock exchange□ transfer □ by agreement

Methods of change of equity Administrative transfer or change of state-owned shares□ Indirect transfer □

(Multiple selections) Obtain new shares issued by listed companies□ □ execution court ruling

Inheritance□ Gift □

Other■Inquiry transfer, passive dilution

Information Disclosure Obligor

Equity before disclosure Type of shares: RMB ordinary shares

Number of shares and number of shares: 26,979,419 shares

Listed company issued shareholding ratio: 6.53%

Proportion of shares

This change in equity

Afterwards, the information disclosure meaning Stock type: RMB ordinary shares

Number of shares held by the employee with interest: 20,769,163 shares

Number of shares and changes Shareholding ratio: 4.99%

proportion

Owned in listed companies: October 2022 to April 2025

Equity share variation: share reduction and passive dilution

When and how it moved

Whether it has been sufficiently disclosed Not applicable

Source

Information Disclosure Obligor

Is it intended for the next 12 Yes□ No■

Continued to increase holdings during the month

Information Disclosure Obligor

In the preceding 6 months it was

NoBuy in the secondary market Yes□ No■

Sell shares of the listed company

ticket

Where the controlling shareholder or actual controller of a listed company is involved in reducing its shareholdings, the information disclosure obligor shall also explain the following contents:

Controlling shareholder or actual

When the controller reduces his holdings, it is

Whether there is infringement of listing Yes□ No□ Not applicable■

Company and Shareholders' Equity

problems

Controlling shareholder or actual

When the controller reduces his holdings, it is

Whether there is any outstanding liquidation

For the company's liabilities, Yes□ No□ Not applicable■

The company has not been terminated (if yes, please specify the specific situation)

Liabilities provided by the burden

protection, or damage to the public

other circumstances of the interests of the Division

shape

Yes □ No□ N/A

Approval is not required

Has been approved Yes□ No□ Not applicable■

(There is no text on this page, it is the attached signed page of the "Report on Changes in Equity in Simplified Form of Shenzhen MGI Technology Co., Ltd.")

Information Disclosure Obligor (Seal): CPE Investment (Hong Kong) 2018 Limited

(Signed):

April 15, 2025

(There is no text on this page, it is the attached signed page of the "Report on Changes in Equity in Simplified Form of Shenzhen MGI Technology Co., Ltd.")

Information disclosure obligor (seal): CHD Biotech Co-invest Limited

(Signed):

April 15, 2025